TScan Therapeutics, Inc.
TCRX
$0.95
-$0.07-6.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -31.97% | -26.75% | 54.62% | 51.06% | 25.85% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 25.19% | 66.40% | 62.38% | 19.11% | 38.29% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -31.35% | -26.17% | 54.71% | 50.70% | 25.98% |
|
|
|||||
| Total Current Assets | -31.35% | -26.17% | 54.71% | 50.70% | 25.98% |
| Net Property, Plant & Equipment | 2.44% | 3.00% | 2.38% | 0.51% | -0.04% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -22.21% | 0.53% | 1.62% | 1.78% | 2.40% |
| Total Assets | -24.65% | -20.36% | 38.15% | 36.37% | 19.44% |
|
|
|||||
| Total Accounts Payable | 74.20% | 45.95% | 133.91% | 80.20% | 14.11% |
| Total Accrued Expenses | -3.27% | 19.37% | 10.33% | 49.00% | 23.83% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 77.12% | -54.92% | -50.95% | -30.68% | -28.95% |
| Total Finance Division Other Current Liabilities | -47.21% | -27.97% | -2.09% | 11.48% | -34.90% |
| Total Other Current Liabilities | -47.21% | -27.97% | -2.09% | 11.48% | -34.90% |
| Total Current Liabilities | 1.91% | -18.80% | -5.28% | 20.58% | -13.55% |
|
|
|||||
| Total Current Liabilities | 1.91% | -18.80% | -5.28% | 20.58% | -13.55% |
| Long-Term Debt | 5.77% | 60.58% | 37.24% | 20.12% | 6.28% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 0.88% | 1.94% | 2.93% | 2.70% | 5.98% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -92.73% | -97.14% | -86.86% | -75.44% | -50.81% |
| Total Liabilities | -0.62% | 1.84% | 3.94% | 7.31% | -2.84% |
|
|
|||||
| Common Stock & APIC | 10.12% | 10.32% | 54.58% | 54.60% | 43.19% |
| Retained Earnings | -42.03% | -44.21% | -47.34% | -51.49% | -48.82% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -37.13% | -30.76% | 70.94% | 59.72% | 35.59% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -37.13% | -30.76% | 70.94% | 59.72% | 35.59% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -37.13% | -30.76% | 70.94% | 59.72% | 35.59% |
|
|
|||||